{"doc":{"info":{"calaisRequestID":"2270d5a2-ecd6-64f1-5e8c-545b881c87bc","id":"http:\/\/id.opencalais.com\/YR8fWQxqxzQB4XfyXiRovg","ontology":"http:\/\/mdaas-virtual-onecalais.int.thomsonreuters.com\/owlschema\/11.0\/onecalais.owl.allmetadata.xml","docId":"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843","document":"Stem Cell Market by Mode of treatment, by Applications, by Technology, by type, and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016-2021)(EMAILWIRE.COM, September 16, 2017 ) Global Stem Cell Market was worth $15.82 billion in 2016 and estimated to reach $30.19 billion by the end of 2021 with a CAGR of 13.8%. The allogeneic stem cell therapy is expected to command the largest share of the market in 2016. The market is expected to grow rapidly because of the extensive research and development which is being done. In the field of life sciences, one of the most promising markets at the moment is the Global Stem Cell Market Growth and is expected to grow exponentially in the coming years as stem cells allow cost-effective treatment of many illnesses that currently have no or ineffective treatment.\n\nRegenerative medicine is perhaps the most important use of stem cells, and other important areas include oncology, hematology, orthopedics, cardiology and neurology. Another widely found application is drug discovery and development. Stem cells are kind of a research tool, as their in vitro study would allow scientists to understand in depth about the role of various organs and the development of particular illnesses; stem cells may also possibly allow drug developers to test emerging therapies on diseased cells. Stem cells therapy has shown substantial potential to treat cancer successfully. Cancer stem cells which have been tested on animals have shown satisfactory results.\n\nBrowse market data tables and in-depth TOC of the Global Stem Cell Market to 2021 @ http:\/\/www.marketdataforecast.com\/market-reports\/global-stem-cell-market-1084\/\n\nSome of the key drivers of stem cell market are improved funding from various government and private organizations for research and development for unmet medical needs, growing industry attention on stem cell research, and increasing global awareness about stem cell therapies. Development of cutting-edge genomic techniques for stem cell analysis, and increasing approvals for clinical trials of stem cell therapy are other factors that are propelling the growth of the market. While on the other hand, ethical issues are involved in the stem cells research and strict regulations to conduct trials on humans are some of the restraining factors. Also factors such as lack of required infrastructure and complications associated with the preservation of stem cell are limiting the growth of the stem cells market.\n\nFree sample of the report is available @http:\/\/www.marketdataforecast.com\/market-reports\/global-stem-cell-market-1084\/request-sample\n\nThe stem cell market is segmented based on the treatment mode, cell types, applications, and technology. Treatment mode is segmented into allogeneic and autologous stem cell therapy. The cells type segment contains adult stem cells, induced pluripotent stem cells, human embryonic stem cells, and others. In the global stem cells market, the adult stem cells hold the highest share, while the market share of induced pluripotent stem cells is likely to grow in the next few years. The technology segment is divided into cell acquisition, cell production, cryopreservation and other sub-segments. On the basis of geography, the global market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. As of now, North America region dominates the global stem cells market. Europe comes next. However, the Asia-Pacific stem cell therapy market is expected to grow the fastest in this forecast period, mainly because of better regulatory support through encouraging government policies and increasing awareness among the public.\n\nInquire before Buying @ http:\/\/www.marketdataforecast.com\/market-reports\/global-stem-cell-market-1084\/inquire\n\nSome of the major players in this market are Athersys, StemCells Inc., Cryo Cell International, Geron Corporation, Mesoblast Ltd., Aastrom Biosciences Inc., Celgene Corporation, Invitrogen and Cytori Therapeutics Inc.\n\nAbout Us:\n\nMarket Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.\n\nVisit Market Data Forecast Blog @ http:\/\/www.marketdataforecast.com\/blog\/\n\nView latest Press Releases of MDF @ http:\/\/www.marketdataforecast.com\/press-releases","docTitle":"","docDate":"2017-09-16 20:14:52.818"},"meta":{"contentType":"text\/raw","processingVer":"AllMetadata","serverVersion":"OneCalais_11.0-RELEASE:169","stagsVer":"OneCalais_11.0-RELEASE-b10-2017-07-31_12:36:53","submissionDate":"2017-09-16 20:14:52.296","submitterCode":"0ca6a864-5659-789d-5f32-f365f695e757","signature":"digestalg-1|1jjOMibnbouaeXNYfgFjXCsYTJY=|VGDNRwC\/NFa8Rs7kHDbxrh1pYUR\/R\/H4U8ju9\/OLjvPdVlfcFTt3ng==","language":"English"}},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/cat\/1":{"_typeGroup":"topics","forenduserdisplay":"false","score":1,"name":"Business_Finance"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/cat\/2":{"_typeGroup":"topics","forenduserdisplay":"false","score":1,"name":"Health_Medical_Pharma"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/cat\/3":{"_typeGroup":"topics","forenduserdisplay":"false","score":0.591,"name":"Technology_Internet"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/lid\/DefaultLangId":{"_typeGroup":"language","language":"http:\/\/d.opencalais.com\/lid\/DefaultLangId\/English","forenduserdisplay":"false","permid":"505062"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/1":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/1","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/a4d237aa-c4e9-3f9b-a26f-70199de66284","forenduserdisplay":"true","name":"Biology","importance":"1","originalValue":"Biology"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/2":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/2","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/8b4f5c27-ca0c-3c6a-a1e2-fc5e7545ea71","forenduserdisplay":"true","name":"Stem cells","importance":"1","originalValue":"Stem cells"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/3":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/3","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/2b4e9812-5030-3d6e-aa8d-1629aeec4ee4","forenduserdisplay":"true","name":"Biotechnology","importance":"1","originalValue":"Biotechnology"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/4":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/4","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/b53cbf2b-b92b-377b-8a92-c6fca48d7d47","forenduserdisplay":"true","name":"Cell biology","importance":"2","originalValue":"Cell biology"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/5":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/5","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/e0e658d3-7943-37f6-b4f4-4952461bfc03","forenduserdisplay":"true","name":"Induced stem cells","importance":"2","originalValue":"Induced stem cells"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/6":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/6","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/9734175c-07f8-3861-9f84-288dc70575c8","forenduserdisplay":"true","name":"Cloning","importance":"2","originalValue":"Cloning"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/7":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/7","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/aa223aa1-8215-32c8-b392-185a1119c120","forenduserdisplay":"true","name":"Stem cell","importance":"2","originalValue":"Stem cell"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/8":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/8","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/3b62c81d-12e2-314a-9edd-a22655870d0f","forenduserdisplay":"true","name":"Stem-cell therapy","importance":"2","originalValue":"Stem-cell therapy"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/9":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/9","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/8363c9bb-7c16-36a2-93ea-a40184516dbd","forenduserdisplay":"true","name":"Adult stem cell","importance":"2","originalValue":"Adult stem cell"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/10":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/10","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/f4a0ed03-e4cd-3281-b72e-fcd21297a6ae","forenduserdisplay":"true","name":"Embryonic stem cell","importance":"2","originalValue":"Embryonic stem cell"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/11":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/11","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/c2ddeb17-44ab-3a75-9b5c-7fdd3bf77740","forenduserdisplay":"true","name":"Induced pluripotent stem cell","importance":"2","originalValue":"Induced pluripotent stem cell"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/12":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/SocialTag\/12","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/29540b13-294a-3c8c-9aa0-b3d44019c925","forenduserdisplay":"true","name":"Cell therapy","importance":"2","originalValue":"Cell therapy"},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/Industry\/1":{"_typeGroup":"industry","forenduserdisplay":"false","name":"Biopharmaceuticals","rcscode":"B:1731","permid":"4294951270","relevance":0.2},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/Industry\/2":{"_typeGroup":"industry","forenduserdisplay":"false","name":"Medical Equipment, Supplies & Distribution - NEC","rcscode":"B:1707","permid":"4294951294","relevance":0.2},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/Industry\/3":{"_typeGroup":"industry","forenduserdisplay":"false","name":"Healthcare Facilities & Services - NEC","rcscode":"B:1717","permid":"4294951284","relevance":0.2},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/Industry\/4":{"_typeGroup":"industry","forenduserdisplay":"false","name":"Biotechnology & Medical Research - NEC","rcscode":"B:1736","permid":"4294951265","relevance":0.2},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/Industry\/5":{"_typeGroup":"industry","forenduserdisplay":"false","name":"Bio Therapeutic Drugs","rcscode":"B:1737","permid":"4294951264","relevance":0.2},"http:\/\/d.opencalais.com\/dochash-1\/1b08685c-b98a-3227-8ccc-55bcc0eb3843\/ComponentVersions":{"_typeGroup":"versions","version":["DIY-Categorization-fnr-TRCS-capx:20170627191152:20170627191152","Deals Index:201709161945:201709161945","DIY-Categorization-fnr-TRCS-indx_stsale:20170323110805:20170323110805","DIY-Categorization-fnr-TRCS-comptn:20170621141739:20170621141739","index-refineries:201705201529:201705201529","DIY-Categorization-fnr-TRCS-regs_buyb_new:20170509091609:20170509091609","config-physicalAssets-powerStations:653:653","NextTags:OneCalais_11.0-RELEASE:169","DIY-Categorization-fnr-TRCS-dis:20170418132337:20170418132337","DIY-Categorization-fnr-TRCS-splitb_r1:20170329082516:20170329082516","config-sca-DataPackage:50:50","config-companyNe:655:655","DIY-Categorization-fnr-TRCS-acb:20170502102348:20170502102348","DIY-Categorization-fnr-TRCS-levrge:20170621122109:20170621122109","DIY-Categorization-fnr-TRCS-hedge_list1:20170315123823:20170315123823","config-refreshableDIY:1:1","People Index:201709161805:201709161805","DIY-Categorization-fnr-TRCS-awlq:20170331124441:20170331124441","config-negativeSignature:653:653","DIY-Categorization-fnr-TRCS-fake1_monop_bnkcap_new:20170405133257:20170405133257","Dial4J:OneCalais_8.6-RELEASE:209","DIY-Categorization-fnr-TRCS-dbtr_new:20170315123740:20170315123740","OA Override:672:672","DIY-Categorization-fnr-TRCS-hrgt:20170427081548:20170427081548","DIY-Categorization-fnr-TRCS-xpand:20170323144646:20170323144646","DIY-Categorization-fnr-TRCS-allcemrgdvst2:20170316142831:20170316142831","DIY-Categorization-fnr-TRCS-ordr:20170313151239:20170313151239","People Override:653:653","DIY-Categorization-fnr-TRCS-hrgt_recll:20170522120000:20170522120000","index-company-oa3:201709152235:201709152235","index-vessels:201709161335:201709161335","DIY-Categorization-fnr-TRCS-brib_r1:20170329090629:20170329090629","config-forEndUserDisplay:3:3","config-refineries:653:653","DIY-Categorization-fnr-TRCS-fapm:20170713144316:20170713144316","DIY-Categorization-fnr-TRCS-class:20170315123207:20170315123207","config-cse:672:672","DIY-Categorization-fnr-TRCS-isu_dat_r:20170315124144:20170315124144","DIY-Categorization-fnr-TRCS-cnsl_sisu:20170321144134:20170321144134","DIY-Categorization-fnr-TRCS-shract_r1:20170412111808:20170412111808","config-vessels:653:653","OneCalais:OneCalais_11.0-RELEASE:169","DIY-Categorization-fnr-TRCS-mktshr2:20170705120412:20170705120412","DIY-RCS-fnr-TRCS-cavs:4:4","DIY-Categorization-fnr-TRCS-trd_tax:20170309132522:20170309132522","DIY-Categorization-fnr-TRCS-sov_2:20170522130956:20170522130956","DIY-Categorization-fnr-TRCS-bons:20170406103713:20170406103713","DIY-Categorization-fnr-TRCS-hrgt_namec:20170329090731:20170329090731","DIY-RCS-fnr-TRCS-nd:3:3","DIY-Categorization-fnr-TRCS-stx:20170530123138:20170530123138","config-physicalAssets-mines:653:653","SocialTags Index:201709031835:201709031835","BlackList:672:672","index-ports:201709091840:201709091840","config-physicalAssets-ports:653:653","DIY-Categorization-fnr-TRCS-ream:20170529065740:20170529065740","DIY-Categorization-fnr-TRCS-chld:20170524084254:20170524084254","DIY-Categorization-fnr-TRCS-allce:20170323145654:20170323145654","DIY-Categorization-fnr-TRCS-medreg:20170508120210:20170508120210","config-drugs:653:653"]},"http:\/\/d.opencalais.com\/comphash-1\/3b629a72-7ae4-367e-a687-5e02a956a57b":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Celgene Corporation","nationality":"N\/A","confidencelevel":"1.0","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[Mesoblast Ltd., Aastrom Biosciences Inc., ]Celgene Corporation[, Invitrogen and Cytori Therapeutics Inc.\n\nAbout]","prefix":"Mesoblast Ltd., Aastrom Biosciences Inc., ","exact":"Celgene Corporation","suffix":", Invitrogen and Cytori Therapeutics Inc.\n\nAbout","offset":3997,"length":19}],"relevance":0.2,"confidence":{"statisticalfeature":"0.881","dblookup":"0.0","resolution":"0.98786104","aggregate":"1.0"},"resolutions":[{"name":"CELGENE CORPORATION","permid":"4295905897","primaryric":"CELG.OQ","ispublic":"true","commonname":"Celgene","score":0.98786104,"id":"https:\/\/permid.org\/1-4295905897","ticker":"CELG"}]},"http:\/\/d.opencalais.com\/genericHasher-1\/ae7bd5ec-9003-37ff-98df-282343699393":{"_typeGroup":"entities","_type":"URL","forenduserdisplay":"false","name":"http:\/\/www.marketdataforecast.com\/press-releases","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/URL","instances":[{"detection":"[latest Press Releases of MDF @ ]http:\/\/www.marketdataforecast.com\/press-releases[]","prefix":"latest Press Releases of MDF @ ","exact":"http:\/\/www.marketdataforecast.com\/press-releases","offset":4589,"length":48}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/ae298e1e-c3f6-38f6-86ac-a19610b1b98a":{"_typeGroup":"entities","_type":"MedicalTreatment","forenduserdisplay":"false","name":"stem cell therapy","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/MedicalTreatment","instances":[{"detection":"[ end of 2021 with a CAGR of 13.8%. The allogeneic ]stem cell therapy[ is expected to command the largest share of the]","prefix":" end of 2021 with a CAGR of 13.8%. The allogeneic ","exact":"stem cell therapy","suffix":" is expected to command the largest share of the","offset":364,"length":17},{"detection":"[and increasing approvals for clinical trials of ]stem cell therapy[ are other factors that are propelling the growth]","prefix":"and increasing approvals for clinical trials of ","exact":"stem cell therapy","suffix":" are other factors that are propelling the growth","offset":2091,"length":17},{"detection":"[ mode is segmented into allogeneic and autologous ]stem cell therapy[. The cells type segment contains adult stem]","prefix":" mode is segmented into allogeneic and autologous ","exact":"stem cell therapy","suffix":". The cells type segment contains adult stem","offset":2807,"length":17},{"detection":"[Europe comes next. However, the Asia-Pacific ]stem cell therapy[ market is expected to grow the fastest in this]","prefix":"Europe comes next. However, the Asia-Pacific ","exact":"stem cell therapy","suffix":" market is expected to grow the fastest in this","offset":3519,"length":17}],"relevance":0.8},"http:\/\/d.opencalais.com\/genericHasher-1\/df18b91e-c25b-391d-a552-c9ae71e627e0":{"_typeGroup":"entities","_type":"Region","forenduserdisplay":"false","name":"Latin America","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Region","instances":[{"detection":"[namely North America, Europe, Asia-Pacific, ]Latin America[ and Middle-East & Africa. As of now, North]","prefix":"namely North America, Europe, Asia-Pacific, ","exact":"Latin America","suffix":" and Middle-East & Africa. As of now, North","offset":3362,"length":13}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/23e3c797-c9e3-3710-804f-492eb78efa19":{"_typeGroup":"entities","_type":"Technology","forenduserdisplay":"false","name":"drug discovery","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Technology","instances":[{"detection":"[neurology. Another widely found application is ]drug discovery[ and development. Stem cells are kind of a]","prefix":"neurology. Another widely found application is ","exact":"drug discovery","suffix":" and development. Stem cells are kind of a","offset":1046,"length":14}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/142c6072-e482-3db0-84ee-44bb9df61316":{"_typeGroup":"entities","_type":"MedicalCondition","forenduserdisplay":"false","name":"cancer","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/MedicalCondition","instances":[{"detection":"[ therapy has shown substantial potential to treat ]cancer[ successfully. Cancer stem cells which have been]","prefix":" therapy has shown substantial potential to treat ","exact":"cancer","suffix":" successfully. Cancer stem cells which have been","offset":1423,"length":6},{"detection":"[potential to treat cancer successfully. ]Cancer[ stem cells which have been tested on animals]","prefix":"potential to treat cancer successfully. ","exact":"Cancer","suffix":" stem cells which have been tested on animals","offset":1444,"length":6}],"relevance":0.2},"http:\/\/d.opencalais.com\/comphash-1\/3d4d7894-295e-35e6-b255-44ff6f90fa84":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"StemCells Inc.","nationality":"N\/A","confidencelevel":"1.0","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[the major players in this market are Athersys, ]StemCells Inc.[, Cryo Cell International, Geron Corporation,]","prefix":"the major players in this market are Athersys, ","exact":"StemCells Inc.","suffix":", Cryo Cell International, Geron Corporation,","offset":3895,"length":14}],"relevance":0.2,"resolutions":[{"name":"MICROBOT MEDICAL INC.","permid":"4295915035","primaryric":"MBOT.OQ","ispublic":"true","commonname":"Microbot Medical","score":0.9947075,"id":"https:\/\/permid.org\/1-4295915035","ticker":"MBOT"}],"confidence":{"statisticalfeature":"0.823","dblookup":"0.0","resolution":"0.9947075","aggregate":"1.0"}},"http:\/\/d.opencalais.com\/comphash-1\/d8573560-d462-3a7e-bffe-81448bf9a925":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Geron Corporation","nationality":"N\/A","confidencelevel":"1.0","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[StemCells Inc., Cryo Cell International, ]Geron Corporation[, Mesoblast Ltd., Aastrom Biosciences Inc.,]","prefix":"StemCells Inc., Cryo Cell International, ","exact":"Geron Corporation","suffix":", Mesoblast Ltd., Aastrom Biosciences Inc.,","offset":3936,"length":17}],"relevance":0.2,"resolutions":[{"name":"GERON CORPORATION","permid":"4295906589","primaryric":"GERN.OQ","ispublic":"true","commonname":"Geron","score":0.9706714,"id":"https:\/\/permid.org\/1-4295906589","ticker":"GERN"}],"confidence":{"statisticalfeature":"0.881","dblookup":"0.0","resolution":"0.9706714","aggregate":"1.0"}},"http:\/\/d.opencalais.com\/genericHasher-1\/364c0ed3-1b52-3735-a911-1b6eaa648277":{"_typeGroup":"entities","_type":"Technology","forenduserdisplay":"false","name":"cell therapy","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Technology","instances":[{"detection":"[2021 with a CAGR of 13.8%. The allogeneic stem ]cell therapy[ is expected to command the largest share of the]","prefix":"2021 with a CAGR of 13.8%. The allogeneic stem ","exact":"cell therapy","suffix":" is expected to command the largest share of the","offset":369,"length":12},{"detection":"[ increasing approvals for clinical trials of stem ]cell therapy[ are other factors that are propelling the growth]","prefix":" increasing approvals for clinical trials of stem ","exact":"cell therapy","suffix":" are other factors that are propelling the growth","offset":2096,"length":12},{"detection":"[ is segmented into allogeneic and autologous stem ]cell therapy[. The cells type segment contains adult stem]","prefix":" is segmented into allogeneic and autologous stem ","exact":"cell therapy","suffix":". The cells type segment contains adult stem","offset":2812,"length":12},{"detection":"[comes next. However, the Asia-Pacific stem ]cell therapy[ market is expected to grow the fastest in this]","prefix":"comes next. However, the Asia-Pacific stem ","exact":"cell therapy","suffix":" market is expected to grow the fastest in this","offset":3524,"length":12}],"relevance":0.8},"http:\/\/d.opencalais.com\/comphash-1\/4a64564b-6713-38ab-831c-bd80f05c1762":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Aastrom Biosciences Inc.","nationality":"N\/A","confidencelevel":"1.0","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[Geron Corporation, Mesoblast Ltd., ]Aastrom Biosciences Inc.[, Celgene Corporation, Invitrogen and Cytori]","prefix":"Geron Corporation, Mesoblast Ltd., ","exact":"Aastrom Biosciences Inc.","suffix":", Celgene Corporation, Invitrogen and Cytori","offset":3971,"length":24}],"relevance":0.2,"resolutions":[{"name":"VERICEL CORPORATION","permid":"4295905396","primaryric":"VCEL.OQ","ispublic":"true","commonname":"Vericel","score":0.98279953,"id":"https:\/\/permid.org\/1-4295905396","ticker":"VCEL"}],"confidence":{"statisticalfeature":"0.834","dblookup":"0.0","resolution":"0.98279953","aggregate":"1.0"}},"http:\/\/d.opencalais.com\/comphash-1\/03806d21-e505-34f2-b62f-4ca170319c49":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"false","name":"Invitrogen","nationality":"N\/A","confidencelevel":"0.599","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[Aastrom Biosciences Inc., Celgene Corporation, ]Invitrogen[ and Cytori Therapeutics Inc.\n\nAbout Us:\n\nMarket]","prefix":"Aastrom Biosciences Inc., Celgene Corporation, ","exact":"Invitrogen","suffix":" and Cytori Therapeutics Inc.\n\nAbout Us:\n\nMarket","offset":4018,"length":10}],"relevance":0.2,"resolutions":[{"name":"LIFE TECHNOLOGIES CORPORATION","permid":"4295913933","ispublic":"false","commonname":"Life Tech Corp","score":0.14062719,"id":"https:\/\/permid.org\/1-4295913933","ticker":"LIFE"}],"confidence":{"statisticalfeature":"0.916","dblookup":"0.0","resolution":"0.14062719","aggregate":"0.599"}},"http:\/\/d.opencalais.com\/comphash-1\/c008b09b-df66-3d8a-bdf8-d63563a71bc7":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"false","name":"Cryo Cell International","nationality":"N\/A","confidencelevel":"0.517","resolutions":[{"name":"CRYO-CELL INTERNATIONAL, INC.","permid":"4295913019","primaryric":"CCEL.PK","ispublic":"true","commonname":"Cryo-Cell Intl","score":0.86474556,"id":"https:\/\/permid.org\/1-4295913019","ticker":"CCEL"}],"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[in this market are Athersys, StemCells Inc., ]Cryo Cell International[, Geron Corporation, Mesoblast Ltd., Aastrom]","prefix":"in this market are Athersys, StemCells Inc., ","exact":"Cryo Cell International","suffix":", Geron Corporation, Mesoblast Ltd., Aastrom","offset":3911,"length":23}],"relevance":0.2,"confidence":{"statisticalfeature":"0.941","dblookup":"0.0","resolution":"0.86474556","aggregate":"0.517"}},"http:\/\/d.opencalais.com\/genericHasher-1\/37f0cf6b-b991-3dc8-8018-78338494cd3a":{"_typeGroup":"entities","_type":"Continent","forenduserdisplay":"false","name":"North America","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Continent","instances":[{"detection":"[market is analysed under various regions namely ]North America[, Europe, Asia-Pacific, Latin America and]","prefix":"market is analysed under various regions namely ","exact":"North America","suffix":", Europe, Asia-Pacific, Latin America and","offset":3325,"length":13},{"detection":"[America and Middle-East & Africa. As of now, ]North America[ region dominates the global stem cells market.]","prefix":"America and Middle-East & Africa. As of now, ","exact":"North America","suffix":" region dominates the global stem cells market.","offset":3413,"length":13}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/09bebb87-1ef5-373d-bd01-263e77470c65":{"_typeGroup":"entities","_type":"Continent","forenduserdisplay":"false","name":"Europe","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Continent","instances":[{"detection":"[under various regions namely North America, ]Europe[, Asia-Pacific, Latin America and Middle-East &]","prefix":"under various regions namely North America, ","exact":"Europe","suffix":", Asia-Pacific, Latin America and Middle-East &","offset":3340,"length":6},{"detection":"[region dominates the global stem cells market. ]Europe[ comes next. However, the Asia-Pacific stem cell]","prefix":"region dominates the global stem cells market. ","exact":"Europe","suffix":" comes next. However, the Asia-Pacific stem cell","offset":3474,"length":6}],"relevance":0.2},"http:\/\/d.opencalais.com\/comphash-1\/7613a166-f84e-394b-a7fe-163aa9715991":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Mesoblast Ltd.","nationality":"N\/A","confidencelevel":"1.0","confidence":{"statisticalfeature":"0.823","dblookup":"0.0","resolution":"0.953323","aggregate":"1.0"},"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[Cryo Cell International, Geron Corporation, ]Mesoblast Ltd.[, Aastrom Biosciences Inc., Celgene Corporation,]","prefix":"Cryo Cell International, Geron Corporation, ","exact":"Mesoblast Ltd.","suffix":", Aastrom Biosciences Inc., Celgene Corporation,","offset":3955,"length":14}],"relevance":0.2,"resolutions":[{"name":"MESOBLAST LIMITED","permid":"4295858844","primaryric":"MSB.AX","ispublic":"true","commonname":"Mesoblast","score":0.953323,"id":"https:\/\/permid.org\/1-4295858844","ticker":"MSB"}]},"http:\/\/d.opencalais.com\/comphash-1\/7d70740b-e796-311c-8929-675da9f25aea":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"false","name":"Athersys","confidencelevel":"0.52","resolutions":[{"name":"ATHERSYS, INC.","permid":"4298015259","primaryric":"ATHX.OQ","ispublic":"true","commonname":"Athersys","score":0.92626154,"id":"https:\/\/permid.org\/1-4298015259","ticker":"ATHX"}],"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[of the major players in this market are ]Athersys[, StemCells Inc., Cryo Cell International, Geron]","prefix":"of the major players in this market are ","exact":"Athersys","suffix":", StemCells Inc., Cryo Cell International, Geron","offset":3885,"length":8}],"relevance":0.2,"confidence":{"statisticalfeature":"0.644","dblookup":"0.0","resolution":"0.92626154","aggregate":"0.52"}},"http:\/\/d.opencalais.com\/genericHasher-1\/19cc1d3f-0865-39b0-b3d6-b3739cf3e66a":{"_typeGroup":"entities","_type":"Continent","forenduserdisplay":"false","name":"Africa","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Continent","instances":[{"detection":"[Asia-Pacific, Latin America and Middle-East & ]Africa[. As of now, North America region dominates the]","prefix":"Asia-Pacific, Latin America and Middle-East & ","exact":"Africa","suffix":". As of now, North America region dominates the","offset":3394,"length":6}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/d7795e80-c9cf-3ffb-8f4f-c5e2440d92dd":{"_typeGroup":"entities","_type":"MedicalTreatment","forenduserdisplay":"false","name":"stem cell therapies","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/MedicalTreatment","instances":[{"detection":"[research, and increasing global awareness about ]stem cell therapies[. Development of cutting-edge genomic techniques]","prefix":"research, and increasing global awareness about ","exact":"stem cell therapies","suffix":". Development of cutting-edge genomic techniques","offset":1951,"length":19}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/a12b43d5-d195-35ea-96a9-f710943bdb5a":{"_typeGroup":"entities","_type":"Position","forenduserdisplay":"false","name":"analyst","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Position","instances":[{"detection":"[of both individual and corporate clients. Our ]analyst[ team comprises expert professionals in market]","prefix":"of both individual and corporate clients. Our ","exact":"analyst","suffix":" team comprises expert professionals in market","offset":4301,"length":7}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/93c8efd3-e0a3-399f-9b77-e2d64814bcfd":{"_typeGroup":"entities","_type":"Region","forenduserdisplay":"false","name":"Asia-Pacific","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Region","instances":[{"detection":"[various regions namely North America, Europe, ]Asia-Pacific[, Latin America and Middle-East & Africa. As of]","prefix":"various regions namely North America, Europe, ","exact":"Asia-Pacific","suffix":", Latin America and Middle-East & Africa. As of","offset":3348,"length":12},{"detection":"[cells market. Europe comes next. However, the ]Asia-Pacific[ stem cell therapy market is expected to grow the]","prefix":"cells market. Europe comes next. However, the ","exact":"Asia-Pacific","suffix":" stem cell therapy market is expected to grow the","offset":3506,"length":12}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/b08bee0d-f76a-3b1f-a74c-645e9bad13ac":{"_typeGroup":"entities","_type":"Technology","forenduserdisplay":"false","name":"stem cells","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Technology","instances":[{"detection":"[to grow exponentially in the coming years as ]stem cells[ allow cost-effective treatment of many illnesses]","prefix":"to grow exponentially in the coming years as ","exact":"stem cells","suffix":" allow cost-effective treatment of many illnesses","offset":734,"length":10},{"detection":"[medicine is perhaps the most important use of ]stem cells[, and other important areas include oncology,]","prefix":"medicine is perhaps the most important use of ","exact":"stem cells","suffix":", and other important areas include oncology,","offset":903,"length":10},{"detection":"[application is drug discovery and development. ]Stem cells[ are kind of a research tool, as their in vitro]","prefix":"application is drug discovery and development. ","exact":"Stem cells","suffix":" are kind of a research tool, as their in vitro","offset":1078,"length":10},{"detection":"[and the development of particular illnesses; ]stem cells[ may also possibly allow drug developers to test]","prefix":"and the development of particular illnesses; ","exact":"stem cells","suffix":" may also possibly allow drug developers to test","offset":1266,"length":10},{"detection":"[to test emerging therapies on diseased cells. ]Stem cells[ therapy has shown substantial potential to treat]","prefix":"to test emerging therapies on diseased cells. ","exact":"Stem cells","suffix":" therapy has shown substantial potential to treat","offset":1363,"length":10},{"detection":"[potential to treat cancer successfully. Cancer ]stem cells[ which have been tested on animals have shown]","prefix":"potential to treat cancer successfully. Cancer ","exact":"stem cells","suffix":" which have been tested on animals have shown","offset":1451,"length":10},{"detection":"[other hand, ethical issues are involved in the ]stem cells[ research and strict regulations to conduct]","prefix":"other hand, ethical issues are involved in the ","exact":"stem cells","suffix":" research and strict regulations to conduct","offset":2233,"length":10},{"detection":"[of stem cell are limiting the growth of the ]stem cells[ market.\n\nFree sample of the report is available]","prefix":"of stem cell are limiting the growth of the ","exact":"stem cells","suffix":" market.\n\nFree sample of the report is available","offset":2489,"length":10},{"detection":"[therapy. The cells type segment contains adult ]stem cells[, induced pluripotent stem cells, human embryonic]","prefix":"therapy. The cells type segment contains adult ","exact":"stem cells","suffix":", induced pluripotent stem cells, human embryonic","offset":2864,"length":10},{"detection":"[contains adult stem cells, induced pluripotent ]stem cells[, human embryonic stem cells, and others. In the]","prefix":"contains adult stem cells, induced pluripotent ","exact":"stem cells","suffix":", human embryonic stem cells, and others. In the","offset":2896,"length":10},{"detection":"[induced pluripotent stem cells, human embryonic ]stem cells[, and others. In the global stem cells market,]","prefix":"induced pluripotent stem cells, human embryonic ","exact":"stem cells","suffix":", and others. In the global stem cells market,","offset":2924,"length":10},{"detection":"[embryonic stem cells, and others. In the global ]stem cells[ market, the adult stem cells hold the highest]","prefix":"embryonic stem cells, and others. In the global ","exact":"stem cells","suffix":" market, the adult stem cells hold the highest","offset":2962,"length":10},{"detection":"[In the global stem cells market, the adult ]stem cells[ hold the highest share, while the market share]","prefix":"In the global stem cells market, the adult ","exact":"stem cells","suffix":" hold the highest share, while the market share","offset":2991,"length":10},{"detection":"[while the market share of induced pluripotent ]stem cells[ is likely to grow in the next few years. The]","prefix":"while the market share of induced pluripotent ","exact":"stem cells","suffix":" is likely to grow in the next few years. The","offset":3072,"length":10},{"detection":"[now, North America region dominates the global ]stem cells[ market. Europe comes next. However, the]","prefix":"now, North America region dominates the global ","exact":"stem cells","suffix":" market. Europe comes next. However, the","offset":3455,"length":10}],"relevance":0.8},"http:\/\/d.opencalais.com\/genericHasher-1\/cf6b8bb8-77c8-33d5-b212-e69bdccdf4e7":{"_typeGroup":"entities","_type":"Technology","forenduserdisplay":"false","name":"business intelligence","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Technology","instances":[{"detection":"[firm working in the area of market research and ]business intelligence[. With rich experience in research across various]","prefix":"firm working in the area of market research and ","exact":"business intelligence","suffix":". With rich experience in research across various","offset":4144,"length":21}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/4a677f82-19cf-3df4-bbf9-f6b4556902f1":{"_typeGroup":"entities","_type":"IndustryTerm","forenduserdisplay":"false","name":"technology segment","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/IndustryTerm","instances":[{"detection":"[is likely to grow in the next few years. The ]technology segment[ is divided into cell acquisition, cell]","prefix":"is likely to grow in the next few years. The ","exact":"technology segment","suffix":" is divided into cell acquisition, cell","offset":3128,"length":18}],"relevance":0.2},"http:\/\/d.opencalais.com\/comphash-1\/55891d38-05a4-3dff-9fe1-9c542ab47942":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Cytori Therapeutics Inc.","nationality":"N\/A","confidencelevel":"1.0","resolutions":[{"name":"CYTORI THERAPEUTICS, INC.","permid":"4295900215","primaryric":"CYTX.OQ","ispublic":"true","commonname":"Cytori","score":0.9923595,"id":"https:\/\/permid.org\/1-4295900215","ticker":"CYTX"}],"confidence":{"statisticalfeature":"0.834","dblookup":"0.0","resolution":"0.9923595","aggregate":"1.0"},"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[Inc., Celgene Corporation, Invitrogen and ]Cytori Therapeutics Inc.[\n\nAbout Us:\n\nMarket Data Forecast is a firm]","prefix":"Inc., Celgene Corporation, Invitrogen and ","exact":"Cytori Therapeutics Inc.","suffix":"\n\nAbout Us:\n\nMarket Data Forecast is a firm","offset":4033,"length":24}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/f561fefe-babc-3891-a3f9-a1d06f266888":{"_typeGroup":"entities","_type":"Technology","forenduserdisplay":"false","name":"Regenerative medicine","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Technology","instances":[{"detection":"[currently have no or ineffective treatment.\n\n]Regenerative medicine[ is perhaps the most important use of stem cells,]","prefix":"currently have no or ineffective treatment.\n\n","exact":"Regenerative medicine","suffix":" is perhaps the most important use of stem cells,","offset":844,"length":21}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/c22051cc-940f-3b60-9aad-fd141441c4b5":{"_typeGroup":"entities","_type":"Region","forenduserdisplay":"false","name":"Middle-East","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Region","instances":[{"detection":"[ America, Europe, Asia-Pacific, Latin America and ]Middle-East[ & Africa. As of now, North America region]","prefix":" America, Europe, Asia-Pacific, Latin America and ","exact":"Middle-East","suffix":" & Africa. As of now, North America region","offset":3380,"length":11}],"relevance":0.2}}